Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment

BACKGROUND: Identification of modifiable risk factors that affect cognitive decline is important for the development of preventive and treatment strategies. Status of paraoxonase 1 (PON1), a high-density lipoprotein-associated enzyme, may play a role in the development of neurological diseases, incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Perła-Kaján, Joanna, Włoczkowska, Olga, Zioła-Frankowska, Anetta, Frankowski, Marcin, Smith, A. David, de Jager, Celeste A., Refsum, Helga, Jakubowski, Hieronim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293656/
https://www.ncbi.nlm.nih.gov/pubmed/33935094
http://dx.doi.org/10.3233/JAD-210137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293656/
https://www.ncbi.nlm.nih.gov/pubmed/33935094
http://dx.doi.org/10.3233/JAD-210137

Ejemplares similares